NCT04939051 2026-03-18
Obeticholic Acid for Prevention in Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06732388 2026-03-18
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT02427269 2025-05-29
BEECAB
University of North Carolina, Chapel Hill
Enrolling by invitation
NCT05524844 2025-05-11
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Columbia University
Completed
NCT05133102 2025-04-20
Longitudinal Oral Microbiome Sampling for BE
Columbia University
Recruiting
NCT02560623 2022-11-17
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Mayo Clinic
Phase NA Completed